145 related articles for article (PubMed ID: 9713943)
21. Assessment of inactivated human rabies vaccines: biochemical characterization and genetic identification of virus strains.
Finke S; Karger A; Freuling C; Müller T
Vaccine; 2012 May; 30(24):3603-9. PubMed ID: 22469862
[TBL] [Abstract][Full Text] [Related]
22. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice.
Yan X; Prosniak M; Curtis MT; Weiss ML; Faber M; Dietzschold B; Fu ZF
J Neurovirol; 2001 Dec; 7(6):518-27. PubMed ID: 11704884
[TBL] [Abstract][Full Text] [Related]
23. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
[TBL] [Abstract][Full Text] [Related]
24. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals.
Madhusudana SN; Anand NP; Shamsundar R
Int J Infect Dis; 2002 Sep; 6(3):210-4. PubMed ID: 12718837
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study.
Lau CL; Hohl N
Travel Med Infect Dis; 2013; 11(6):427-30. PubMed ID: 24135254
[TBL] [Abstract][Full Text] [Related]
26. Comparative studies on chick embryo cell rabies vaccine and human diploid cell vaccine: pre-exposure use and purity of the vaccines.
Arai YT; Montalban CS
Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):747-50. PubMed ID: 7939952
[TBL] [Abstract][Full Text] [Related]
27. Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man.
Nicholson KG; Farrow PR; Bijok U; Barth R
Vaccine; 1987 Sep; 5(3):208-10. PubMed ID: 3673207
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA
Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019
[TBL] [Abstract][Full Text] [Related]
29. Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG.
Peng J; Chen L; Zhu ZG; Zhu ZR; Hu Q; Fang Y
Hum Vaccin Immunother; 2014; 10(12):3622-6. PubMed ID: 25668669
[TBL] [Abstract][Full Text] [Related]
30. Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis.
Dietzschold B; Morimoto K; Hooper DC; Smith JS; Rupprecht CE; Koprowski H
J Hum Virol; 2000; 3(1):50-7. PubMed ID: 10774807
[TBL] [Abstract][Full Text] [Related]
31. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization.
Dreesen DW; Fishbein DB; Kemp DT; Brown J
Vaccine; 1989 Oct; 7(5):397-400. PubMed ID: 2815976
[TBL] [Abstract][Full Text] [Related]
32. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N
Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608
[TBL] [Abstract][Full Text] [Related]
33. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML.
Madhusudana SN; Sanjay TV; Mahendra BJ; Sudarshan MK; Narayana DH; Giri A; Muhamuda K; Ravi V; Vakil HB; Malerczyk C
Hum Vaccin; 2006; 2(5):200-4. PubMed ID: 17035734
[TBL] [Abstract][Full Text] [Related]
34. Cross-protection of mice against a global spectrum of rabies virus variants.
Lodmell DL; Smith JS; Esposito JJ; Ewalt LC
J Virol; 1995 Aug; 69(8):4957-62. PubMed ID: 7609065
[TBL] [Abstract][Full Text] [Related]
35. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK
Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792
[TBL] [Abstract][Full Text] [Related]
36. Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man.
Scheiermann N; Baer J; Hilfenhaus J; Marcus I; Zoulek G
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):439-50. PubMed ID: 2445127
[TBL] [Abstract][Full Text] [Related]
37. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
[TBL] [Abstract][Full Text] [Related]
38. Antibody responses to human diploid cell vaccine for rabies with and without human rabies immune globulin.
Mertz GJ; Nelson KE; Vithayasai V; Makornkawkeyoon S; Rosanoff EI; Tint H; Wiktor TJ
J Infect Dis; 1982 May; 145(5):720-7. PubMed ID: 7077095
[TBL] [Abstract][Full Text] [Related]
39. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett SM; Levis R; Meltzer MI; Schaffner W; Cieslak PR;
MMWR Recomm Rep; 2010 Mar; 59(RR-2):1-9. PubMed ID: 20300058
[TBL] [Abstract][Full Text] [Related]
40. Calculating rabies virus neutralizing antibodies titres by flow cytometry.
Bordignon J; Comin F; Ferreira SC; Caporale GM; Lima Filho JH; Zanetti CR
Rev Inst Med Trop Sao Paulo; 2002; 44(3):151-4. PubMed ID: 12163908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
